Monitoring metastatic melanoma treatment resistance using circulating tumour DNA

被引：0
|
作者：
Murphy, S. [1 ]
Wan, J. [1 ]
Gale, D. [1 ]
Morris, J. [1 ]
Mouliere, F. [1 ]
Bignell, G. [2 ]
Alifrangis, C. [2 ]
Parkinson, C. [3 ]
Durrani, A. [4 ]
McDermott, U. [2 ]
Massie, C. [1 ]
Corrie, P. [3 ]
Rosenfeld, N. [1 ]
机构：
[1] Canc Res UK Cambridge Res Inst, Rosenfeld Grp, Cambridge, England
[2] Wellcome Trust Sanger Inst, Hinxton, England
[3] Addenbrookes Hosp, Dept Oncol, Cambridge, England
[4] Addenbrookes Hosp, Dept Plast Surg, Cambridge, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
10.1016/S0959-8049(16)61694-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
853
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [31] Early identification of treatment effect by methylated circulating tumour DNA in metastatic colorectal cancer
    Thomsen, C. B.
    Hansen, T. F.
    Andersen, R. F.
    Jensen, L. H.
    Jakobsen, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer
    Fribbens, C.
    Murillas, I. Garcia
    Beaney, M.
    Hrebien, S.
    O'Leary, B.
    Kilburn, L.
    Howarth, K.
    Epstein, M.
    Green, E.
    Rosenfeld, N.
    Ring, A.
    Johnston, S.
    Turner, N.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 145 - 153
  • [33] Circulating tumour DNA to monitor treatment response and resistance in chronic lymphocytic leukemia
    Sinha, Devbarna
    Ftouni, Sarah
    Hunter, Tane
    Yeh, Paul
    Wallach, Elise
    Wong, Stephen
    Petrone, Pasquale
    Seymour, John F.
    Dawson, Mark A.
    Tam, Constantine
    Dawson, Sarah-Jane
    LEUKEMIA & LYMPHOMA, 2015, 56 : 80 - 80
  • [34] Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA
    Ye, Liu-Fang
    Huang, Zi-Yao
    Chen, Xiao-Xi
    Chen, Zhi-Gang
    Wu, Si-Xian
    Ren, Chao
    Hu, Ming-Tao
    Bao, Hua
    Jin, Ying
    Wang, Feng
    Wang, Feng-Hua
    Du, Zi-Ming
    Wu, Xue
    Ju, Huai-Qiang
    Shao, Yang
    Li, Yu-Hong
    Xu, Rui-Hua
    Wang, De-Shen
    DRUG RESISTANCE UPDATES, 2022, 65
  • [35] Monitoring treatment response and toxicity in BRAF V600-mutant metastatic melanoma with circulating cell-free DNA
    Jain, Sidharth S.
    McDeed, A. Patrick
    McNamara, Megan E.
    Alley, Amber R.
    Rosenstrauch, Dori S.
    Sun, Harry
    Thompson, Natalie
    Kirkwood, John M.
    Gibney, Geoffrey T.
    Atkins, Michael B.
    Wellstein, Anton
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [36] Circulating tumour cells mRNA in treatment strategy for melanoma
    Abramov, A.
    Petkevich, A.
    Ogurtsov, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Circulating tumour DNA in patients with melanoma receiving targeted therapy
    Forschner, Andrea
    LANCET ONCOLOGY, 2021, 22 (03): : 291 - 293
  • [38] Monitoring gastric cancer progression with circulating tumour DNA
    T Hamakawa
    Y Kukita
    Y Kurokawa
    Y Miyazaki
    T Takahashi
    M Yamasaki
    H Miyata
    K Nakajima
    K Taniguchi
    S Takiguchi
    M Mori
    Y Doki
    K Kato
    British Journal of Cancer, 2015, 112 : 352 - 356
  • [39] Monitoring gastric cancer progression with circulating tumour DNA
    Hamakawa, T.
    Kukita, Y.
    Kurokawa, Y.
    Miyazaki, Y.
    Takahashi, T.
    Yamasaki, M.
    Miyata, H.
    Nakajima, K.
    Taniguchi, K.
    Takiguchi, S.
    Mori, M.
    Doki, Y.
    Kato, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 352 - 356
  • [40] Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
    Herbreteau, Guillaume
    Vallee, Audrey
    Knol, Anne-Chantal
    Theoleyre, Sandrine
    Quereux, Gaelle
    Frenard, Cecile
    Varey, Emilie
    Hofman, Paul
    Khammari, Amir
    Dreno, Brigitte
    Denis, Marc G.
    CANCERS, 2020, 12 (07) : 1 - 13
12345